Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into Nanoparticles

Author(s)
Melo, Mariane Bandeira; Porter, Ely; Zhang, Yuan; Silva, Murillo; Li, Na; ... Show more
Thumbnail
DownloadPublished version (1.642Mb)
Publisher with Creative Commons License
Terms of use
Creative Commons Attribution-NonCommercial-NoDerivs License http://creativecommons.org/licenses/by-nc-nd/4.0/
Metadata
Show full item record
Abstract
Self-replicating RNAs derived from alphaviruses have high potential for vaccine applications. Utilizing lipid nanoparticle-formulated RNA replicons as a vaccine platform to deliver self-assembling protein immunogens, Melo et al. demonstrate robust anti-HIV Env antibody production and significantly improved antigen-specific B cell activation in vaccinated mice when compared with protein immunization.
Date issued
2019-12
URI
https://hdl.handle.net/1721.1/129330
Department
Massachusetts Institute of Technology. Synthetic Biology Center; Massachusetts Institute of Technology. Department of Biological Engineering; Massachusetts Institute of Technology. Department of Materials Science and Engineering; Koch Institute for Integrative Cancer Research at MIT
Journal
Molecular Therapy
Publisher
Elsevier BV
Citation
Melo, Mariane et al. "Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into Nanoparticles." Molecular Therapy 27, 12 (December 2019): P2080-2090 © 2019 The American Society of Gene and Cell Therapy
Version: Final published version
ISSN
1525-0016
Collections